Two newly approved drugs in Australia may be able to do what was once thought impossible: slow the rate of cognitive decline ...

Alzheimer's dementia accounts for about 50% to 80% of dementia cases, vascular dementia for 20% to 30%, Lewy body dementia ...

For the millions of people worldwide living with dementia, medication management presents unique challenges. While certain drugs help manage symptoms and slow cognitive decline, others can ...

Understanding the strategies and unmet needs of caregivers managing medications for people with Alzheimer's disease or related dementias may improve the lives of both caregivers and patients. A recent ...

Research conducted by the University of Cambridge and the University of Exeter examined large datasets to uncover correlations between medications and cognitive health. The findings suggest that ...

There has been a lot of chatter over the past year about the positive impacts of diabetes medications—like Ozempic—on a slew of serious health conditions. Now, there’s a new type of prescription ...

There's currently no cure for dementia. Although some recently developed drugs show promise in slowing the progress of the disease, these are both costly and may have limited benefit for many patients ...

A Michigan family’s dispute over sedating medications highlights the risks, challenges, and difficult care decisions ...

For the first time, the pipeline of innovative diagnostic tests and treatments for Alzheimer's disease and other dementias is rapidly expanding.

Psychotropic medications commonly used to treat posttraumatic stress disorder (PTSD) are associated with increased risk for dementia in older veterans, new research shows. "Patients diagnosed with ...

Novo Nordisk and Eli Lilly say GLP-1 drugs slowed aging clocks, but the data are early and unreviewed. Here is what patients should know. A study of 1.4 million women links pregnancy complications to ...